
Sign up to save your podcasts
Or


After swearing off startups post a $300 million exit, Karan Bajaj is back with Complement 1, a healthtech venture offering personalised coaching for cancer patients. But this isn’t just a pivot, it’s a whole new playbook.
This time, it’s personal: Bajaj’s mother had cancer, and he says this is the product he wishes she had.
Built for the American market, Complement 1 is taking a B2B route, targeting insurers, employers, and cancer centres. But early traction has been tough. Unlike edtech, healthcare demands more than just hustle. We look at whether Bajaj’s old playbook still works in a world where good intentions must meet rigorous standards and sustainable business models.
Tune in.
By The Ken5
99 ratings
After swearing off startups post a $300 million exit, Karan Bajaj is back with Complement 1, a healthtech venture offering personalised coaching for cancer patients. But this isn’t just a pivot, it’s a whole new playbook.
This time, it’s personal: Bajaj’s mother had cancer, and he says this is the product he wishes she had.
Built for the American market, Complement 1 is taking a B2B route, targeting insurers, employers, and cancer centres. But early traction has been tough. Unlike edtech, healthcare demands more than just hustle. We look at whether Bajaj’s old playbook still works in a world where good intentions must meet rigorous standards and sustainable business models.
Tune in.

38 Listeners

152 Listeners

16 Listeners

57 Listeners

53 Listeners

88 Listeners

40 Listeners

280 Listeners

40 Listeners

25 Listeners

7 Listeners

14 Listeners

122 Listeners

92 Listeners

12 Listeners

14 Listeners

4 Listeners

0 Listeners

0 Listeners

0 Listeners